跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUGAMMADEX BEXAL 100 MG/ML SOLUCION INYECTABLE EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUGAMMADEX BEXAL 100 MG/ML SOLUCION INYECTABLE EFG
Approved
STANDARD
SUGAMMADEX BEXAL 100 MG/ML SOLUCION INYECTABLE EFG
Bexal Farmaceutica S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Dec 28, 2022
Approval ID
a59d29ea985b16d2
Company
Bexal Farmaceutica S.A.
Type
Standard
Approval Details
Approval Id
a59d29ea985b16d2
Drug Cima Aemps Name
SUGAMMADEX BEXAL 100 MG/ML SOLUCION INYECTABLE EFG
Register Number
88350
Holder Company Name
Bexal Farmaceutica S.A.
Marketing Company Name
Bexal Farmaceutica S.A.
Authorization Date
2022-12-28
Dosage Form
SOLUCIÓN INYECTABLE
Dose
100 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Bexal Farmaceutica S.A.
Active Ingredients
SUGAMMADEX SODIO
108,8 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Dec 28, 2022
Approval ID
a59d29ea985b16d2
Type
Standard
Back to CIMA-AEMPS Approvals
